leadf
logo-loader
viewPropanc Biopharma, Inc.

Propanc Biopharma boosts its patent portfolio for its anti-cancer therapy

Propanc Biopharma Inc (OTCMTKS:PPCBD) CEO James Nathanielsz tells Proactive Investors the company has boosted its intellectual property portfolio for its anti-cancer technology currently in development.

The biopharmaceutical company’s portfolio now has 65 patents either in force or pending in most major countries around the globe. Nathanielsz also updated investors on the reasoning behind the company's recent reverse stock split.

Quick facts: Propanc Biopharma, Inc.

Price: - -

OTCMKTS:PPCB
Market: OTCQB
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

PyroGenesis Canada to supply plasma torch for $1.8M with major iron ore producer

PyroGenesis Canada Inc (CVE:PYR) (OTCQB:PYRNF) (FRA:8PY) CEO Peter Pascali tells Proactive the group has signed an initial contract to provide a high-powered, one-megawatt plasma torch with accessories to a major iron ore producer for around $1.8 million. Pascali says the Montreal-based...

15 hours, 13 minutes ago

2 min read